Pfizer's antifungal drug Diflucan, or fluconazole, appears to heighten the risk of certain birth defects when taken frequently in high dosage within the first trimester of pregnancy, according to an FDA warning. The agency reclassified from Category C to D the extended use of high-dose Diflucan for maternal indications other than vaginal yeast infection.

Related Summaries